Related Experiment Video
Updated: May 5, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
56.5K
Thoracic duct changes in schistosomal hepatic fibrosis
Gut
|January 1, 1970
Summary
In schistosomiasis-related liver fibrosis with ascites, the thoracic duct (TD) shows dilation, increased pressure, and elevated lymph flow. These thoracic duct changes are significant for understanding and treating ascites.
Area of Science:
- Gastroenterology
- Hepatology
- Vascular Biology
Background:
- Schistosomiasis is a major cause of hepatic fibrosis worldwide.
- Ascites is a common and serious complication of advanced liver disease.
- The role of the thoracic duct in hepatic fibrosis with ascites is not fully understood.
Purpose of the Study:
- To investigate the morphological and functional changes of the thoracic duct in schistosomiasis-induced hepatic fibrosis, especially in patients with ascites.
- To elucidate the implications of these thoracic duct alterations for ascites formation and management.
Main Methods:
- Postmortem examination of thoracic duct.
- Lymphangiography to visualize lymphatic vessels.
- Clinical thoracic duct cannulation to measure pressure and flow.
Main Results:
- Thoracic duct dilation was observed, particularly in cases with ascites.
- Elevated pressure within the thoracic duct was detected.
- Increased lymph flow through the thoracic duct was a consistent finding.
Conclusions:
- Thoracic duct alterations, including dilation and increased lymph flow, are significant in schistosomiasis-related hepatic fibrosis with ascites.
- Understanding these lymphatic changes is crucial for developing effective therapeutic strategies for ascites.
Related Concept Videos
01:16Lymphatic Vessels and Lymph Transport
13.6K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
13.6K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:23Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
01:22Portal Hypertension
50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
01:21Chronic Pancreatitis II: Pathophysiology
30
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30